Ola Engkvist

Professor Ola Engkvist is Executive Director in Discovery Sciences, AstraZeneca R&D. He is currently leading the Molecular AI department, where the focus is to develop novel methods for ML/AI in drug design. He has published over 170 peer-reviewed scientific publications. He is adjunct professor in machine learning and AI for drug design at Chalmers University of Technology and a trustee of Cambridge Crystallographic Data Center. In addition, he is also a Fellow of the European Laboratory for Learning and Intelligent Systems (ELLIS).